Cumberland Pharmaceuticals Ownership | Who Owns Cumberland Pharmaceuticals?


OverviewRevenueFinancialsChartTranscripts

Cumberland Pharmaceuticals Ownership Summary


Cumberland Pharmaceuticals is owned by 14.54% institutional investors, 44.72% insiders, and 40.74% retail investors. Renaissance is the largest institutional shareholder, holding 3.82% of CPIX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.00% of its assets in Cumberland Pharmaceuticals shares.

CPIX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCumberland Pharmaceuticals14.54%44.72%40.74%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.90%10.53%54.58%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Renaissance538.16K3.82%$823.39K
Vanguard group374.25K2.65%$572.60K
Dimensional fund advisors lp304.11K2.16%$465.29K
Bridgeway capital management286.65K2.03%$438.58K
Acadian asset management188.16K1.33%$286.00K
Blackrock110.56K0.78%$169.16K
Geode capital management88.75K0.63%$135.80K
Bank of new york mellon75.27K0.53%$115.16K
State street33.70K0.24%$51.56K
Cresset asset management21.02K0.15%$32.17K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bridgeway capital management286.65K0.01%$438.58K
Renaissance538.16K0.00%$823.39K
Acadian asset management188.16K0.00%$286.00K
Oakworth capital3.05K0.00%$4.67K
Tower research capital llc (trc)6.61K0.00%$10.11K
Cresset asset management21.02K0.00%$32.17K
Two sigma investments, lp19.33K0.00%$29.57K
Dimensional fund advisors lp304.11K0.00%$465.29K
Bank of america corp /de/67.00-$103.00
Advisor group100.00-$153.00

Top Buyers

HolderShares% AssetsChange
Cresset asset management21.02K0.00%9.00K
Ubs group6.87K-5.08K
Geode capital management88.75K-4.22K
Tower research capital llc (trc)6.61K0.00%861.00
Bank of america corp /de/67.00-67.00

Top Sellers

HolderShares% AssetsChange
Dimensional fund advisors lp304.11K0.00%-53.51K
Two sigma advisers, lp---23.00K
Two sigma investments, lp19.33K0.00%-13.10K
Morgan stanley2.66K--8.61K
Renaissance538.16K0.00%-4.50K

Sold Out

HolderChange
Wells fargo & company/mn-65.00
Innealta capital-948.00
Two sigma advisers, lp-23.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202423-4.17%2,043,812-1.62%146.70%950.00%4-20.00%
Jun 30, 202424-2,077,457-3.95%146.44%620.00%5-44.44%
Mar 31, 202424-4.00%2,162,869-1.58%156.39%5-37.50%950.00%
Dec 31, 20232513.64%2,197,513-0.47%156.54%860.00%6-
Sep 30, 202322-8.33%2,207,792-7.97%155.50%5-16.67%6-14.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv280.82K2.00%-
Bridgeway Ultra-Small Company233.07K1.65%-
Vanguard Institutional Extnd Mkt Idx Tr84.24K0.60%-
DFA US Targeted Value I79.72K0.57%-
Bridgeway Ultra-Small Company Market49.89K0.36%-
DFA US Micro Cap I47.77K0.34%-
Fidelity Extended Market Index41.65K0.30%-3.24K
Dimensional US Targeted Value ETF39.28K0.28%-
Dimensional US Marketwide Value ETF23.32K0.17%-
Dimensional US Small Cap ETF18.70K0.13%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 26, 2024Young Caroline-Buy$17.44
Nov 25, 2024Young Caroline-Buy$17.44
Nov 29, 2024Young Caroline-Buy$21.12
Nov 27, 2024Young Caroline-Buy$18.40
Nov 22, 2024Young Caroline-Buy$17.12

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q1--
2024 Q3--
2024 Q2--
2024 Q1--

CPIX Ownership FAQ


Who Owns Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals shareholders are primarily institutional investors at 14.54%, followed by 44.72% insiders and 40.74% retail investors. The average institutional ownership in Cumberland Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.90%, which Cumberland Pharmaceuticals falls below.

Who owns the most shares of Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals’s largest shareholders are Renaissance (538.16K shares, 3.82%), Vanguard group (374.25K shares, 2.65%), and Dimensional fund advisors lp (304.11K shares, 2.16%). Together, they hold 8.63% of Cumberland Pharmaceuticals’s total shares outstanding.

Does Blackrock own Cumberland Pharmaceuticals?

Yes, BlackRock owns 0.78% of Cumberland Pharmaceuticals, totaling 110.56K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 169.16K$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Cumberland Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bridgeway capital management is Cumberland Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 286.66K Cumberland Pharmaceuticals shares, valued at 438.58K$.

Who is the top mutual fund holder of Cumberland Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cumberland Pharmaceuticals shares, with 2.00% of its total shares outstanding invested in 280.82K Cumberland Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools